Uveitis Associated with Psoriatic Arthritis: Characteristics, Approaches, and TreatmentDecember 4, 2023Psoriatic Arthritis
Commentary: PsA domains and analysis of various biologics in PsA, August 2023July 31, 2023Psoriatic Arthritis
Serum neutrophil gelatinase-associated lipocalin levels show no correlation with PsA outcomesJuly 24, 2023Psoriatic Arthritis
Increased prevalence of subclinical myocardial dysfunction in PsA with higher disease activityJuly 24, 2023Psoriatic Arthritis
Anti-TNF-α therapy reduces incidence of nailfold capillaroscopic abnormalities in PsAJuly 24, 2023Psoriatic Arthritis
Improvement in patient-reported outcomes comparable with ustekinumab and TNFi in PsAJuly 24, 2023Psoriatic Arthritis
Apremilast offers a safe long-term oral treatment option for psoriatic arthritisJuly 24, 2023Psoriatic Arthritis
Predictors of treatment response in PsA patients initiating a first TNFiJuly 24, 2023Psoriatic Arthritis
Beta-defensin-2 may serve as a predictive biomarker for clinical response to secukinumab in PsAJuly 24, 2023Psoriatic Arthritis
